Vaccines Applications
-
Premium
Advanced FT-NIR Solutions for Pharmaceutical Development and Manufacturing Sector
The pharmaceutical industry includes discovering, developing, producing, and marketing drugs to be used as medications and vaccines to treat and cure patients across the globe. The modern pharmaceutical industry began in the early 1800s and continues to grow rapidly until this day. For example, in 2018, cancer drugs made nearly 100 billion U.S. dollars of revenue ...
By Galaxy Scientific Inc based in Nashua, NEW HAMPSHIRE (USA).
-
LCL-161
LCL161 is an orally bioavailable second mitochondrial-derived activator of caspases (SMAC) mimetic and inhibitor of IAP (Inhibitor of Apoptosis Protein) family of proteins. https://www.bocsci.com/lcl-161-cas-1005342-46-0-item-462558.html ...
By Alfa Chemistry based in NY, NEW YORK (USA).
-
Uprosertib
Uprosertib, also known as GSK2141795 and GSK795, is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. https://www.bocsci.com/uprosertib-cas-1047634-65-0-item-462537.html ...
By Alfa Chemistry based in NY, NEW YORK (USA).
-
Data integrity, regulatory compliance solutions for bio-/pharmaceutical industry
When you’re developing the next generation of small molecule therapeutics, biologics, or vaccines, getting reliable data is critical for success. So is speed. With products and services that can boost productivity, support regulatory compliance, and shorten time-to-market while ensuring high-quality assay results, Artel is helping BioPharma teams get ahead and stay ...
By Artel, Inc. by Advanced Instruments based in Westbrook, MAINE (USA).
-
Shredding solutions for hospital waste industry
This category includes various products and materials collected in hospitals: hazardous waste (eg catheters, disposable gloves, test tubes, disposable gowns, material for dressing, etc.). lab hazardous waste as a result of the carrying out of research activities and bacteriological diagnostics (for example: land plates, contaminated culture, etc.). cutting waste (for example: needles, syringes, scalpels, etc.). unrecognizable organs and body parts empty containers (for example: of medicines, of disinfectants, of ...
By SatrindTech Srl based in Arluno, ITALY.
-
Oral Surgery
Lasers have been used in dentistry for approximately two decades. For many intraoral soft tissue surgical procedures, the laser is a viable alternative to the scalpel. There are many categories of soft tissue procedures that can be treated by ...
By PIOON based in Wuhan, CHINA.
-
Medical solutions for vaccine platform sector
2A Pharma’s vaccine platform is based on mutated parvoviral particles consisting essentially of one protein. The particles contain no viral genome and are replicative defective and non-pathogenic. The particle capsid surface has repetitive, immunogenic sites, where peptides of interest can be inserted and allows us to generate monovalent or bivalent vaccines as required. Each peptide of interest will be presented 60 times on the capsid surface and both the innate and adaptive immune systems are activated to ...
By 2A Pharma ApS based in Aalborg Øst, DENMARK.
-
Predict Health Monitoring
Predict Health Monitoring provides online Occupational Health Screening Assessment Tools, giving insight into the health status of your work force at any one ...
By Enigma based in Auckland, NEW ZEALAND.
-
RNA Technology for Clinical trials
Our collective health depends on finding new vaccines and treatments for diseases and illnesses. Clinical trials are pivotal in getting medicines approved to help people in need. We invite you to learn about our clinical trial opportunities and how you may be able to make a ...
By Moderna, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
Software Solutions for Sponsors
Maximize the probability of your clinical trial success by accelerating patient enrollment and flexible operations. Whether it is investigator-initiated study, observational study, phase 0, 1, 2, 3, or 4 post-market trials, real-world evidence generation to supplement your randomized controlled clinical trial, maximizing the speed of patient enrollment is the proven way to minimize your ...
By Jeeva Informatics Solutions Inc. based in Manassas, VIRGINIA (USA).
-
Synthesis and machine learning driven techniques solutions for vaccine development sector
Enable different strategies for vaccine development to attack rapidly mutating viruses such as influenza, HCV, HIV, or coronaviruses. Use our platform to assist in the creation and optimization of different types of vaccines such as virus-like particles (VLPs), DNA vaccines, RNA ...
By TeselaGen Biotechnology, Inc. based in Portola Valley, CALIFORNIA (USA).
-
Software Solutions for COVID-19
As the COVID-19 pandemic continues, the SARS-CoV-2 virus is likely to become endemic with emerging novel variants, some of them seasonal. Updates to the various vaccines will be required, as will a range of anti-virals with a variety of mechanisms of action, for use in early infection and in hospitalizated patients, much like oseltamivir (Tamiflu) is used in certain populations for seasonal ...
By Cyrus Biotechnology Inc. based in Seattle, WASHINGTON (USA).
-
Nanoparticle Concentration Analysis Device for Viruses Industry
A virus is biological nanoparticle with a size of 20 to 500 nm. A virus is a biological infective agent that infect living hosts and reproduces inside the host cells. Viral infect all forms of life; can cause disease in humans, animals, plants and even insects. Unlike most living things, viruses do not have cells that divide; new viruses are assembled in the infected host cells. Viruses contain genetic materials (either DNA or RNA) which give them the ability to mutate and evolve. It also has a protective coat ...
By Dispertech B.V. based in Amsterdam, NETHERLANDS.
-
Focal Molography Solution for Cell and Gene Therapy
Simple and robust determination of critical quality attributes in ...
By lino Biotech AG based in Zurich, SWITZERLAND.
-
Proprietary Technologies for Approach Towards COVID-19
First generation COVID-19 vaccines generate a strong antibody response against SARS-CoV-2, the virus that causes COVID-19. These vaccines elicit neutralizing antibodies that can recognize the surface Spike protein of the virus and attack it before it infects cells. However, antibody responses may wane over time and long-term durability of protection remains unknown. Additionally, mutations in SARS-CoV-2 continuously arise, including in the Spike protein, and may further reduce clinical protection derived from ...
By Gritstone Bio based in Emeryville, CALIFORNIA (USA).
-
Needle-free Delivery of Nucleic Acid Vaccines
The Nucleic Acid Vaccine Revolution is Just the Beginning. When they write the history of vaccines, this will probably be a turning point: Nucleic acid vaccines have shifted the immunology landscape with unrivaled speed and impact. While the world is focused on the rollout of COVID-19 vaccines, the race for the next generation of nucleic acid vaccines and therapeutics – targeted at a variety of other diseases – is on! There is now sufficient evidence to conclude that nucleic products can be improved ...
By PharmaJet based in Golden, COLORADO (USA).
-
Microscopy Technology for Pathogens Hub
Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi or prions. Thanks to scientific advances in microbiology, host-pathogen interactions, and drug development, many of these infections can now be controlled or cured. Despite great efforts and the development of advanced technologies to investigate infectious agents, there are still many open questions regarding pathogen life cycles, how they cause disease and how can they be ...
By ONI based in Oxford, UNITED KINGDOM.
-
Needle-free Injection System for Influenza Vaccine Industry
The first vaccine in the US labeled for needle-free delivery. Afluria® and Afluria QIV Influenza Vaccines are FDA Approved for use with the PharmaJet Stratis® Jet Injector Needle-free System. The Stratis Needle-free Injector is the first needle-free jet injector that is FDA approved for delivery of an influenza vaccine. A comprehensive clinical trial demonstrated that needle-free flu vaccine delivery with Afluria® is comparable to administration using a needle and syringe for adults aged 18-64. ...
By PharmaJet based in Golden, COLORADO (USA).
-
RNA Technology for Medical Areas of Focus Research
Using our platform, we are developing mRNA medicines for diverse uses and delivering them to patients across the globe. We are currently focusing on 4 medical areas - infectious diseases, immuno-oncology, rare diseases and autoimmune ...
By Moderna, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
Protein and Vaccine Production for Vaccine manufacturing industry
Vaccine manufacturing has been widely popular ever since Pasteur developed the rabies vaccine in 1885. Since then vaccine manufacturing has continued to be popular due to the defense that vaccines provide against certain viruses. The human immune system is constantly defending itself against a barrage of viruses and we simply lack the capacity to recognize and fight against these ever changing pathogens. Vaccines are designed to help mobilize the host’s immune system to prevent virus infections and break the ...
By Lonza Group Ltd based in Basel, SWITZERLAND.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you